DTIL
Price
$4.82
Change
-$0.40 (-7.66%)
Updated
Nov 19 closing price
Capitalization
116.03M
Intraday BUY SELL Signals
TCRX
Price
$1.03
Change
+$0.04 (+4.04%)
Updated
Nov 19 closing price
Capitalization
58.45M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DTIL vs TCRX

Header iconDTIL vs TCRX Comparison
Open Charts DTIL vs TCRXBanner chart's image
Precision BioSciences
Price$4.82
Change-$0.40 (-7.66%)
Volume$388.35K
Capitalization116.03M
TScan Therapeutics
Price$1.03
Change+$0.04 (+4.04%)
Volume$927.19K
Capitalization58.45M
DTIL vs TCRX Comparison Chart in %
DTIL
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DTIL vs. TCRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (DTIL: $4.82 vs. TCRX: $1.03)
Brand notoriety: DTIL and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 215% vs. TCRX: 116%
Market capitalization -- DTIL: $116.03M vs. TCRX: $58.45M
DTIL [@Biotechnology] is valued at $116.03M. TCRX’s [@Biotechnology] market capitalization is $58.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • DTIL’s TA Score: 4 bullish, 6 bearish.
  • TCRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both DTIL and TCRX are a bad buy in the short-term.

Price Growth

DTIL (@Biotechnology) experienced а -19.67% price change this week, while TCRX (@Biotechnology) price change was -13.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DTIL($116M) has a higher market cap than TCRX($58.5M). DTIL YTD gains are higher at: 26.509 vs. TCRX (-66.118). DTIL has higher annual earnings (EBITDA): -73.73M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. DTIL (62.2M). DTIL has less debt than TCRX: DTIL (29.4M) vs TCRX (96.7M). TCRX has higher revenues than DTIL: TCRX (6.96M) vs DTIL (1.26M).
DTILTCRXDTIL / TCRX
Capitalization116M58.5M198%
EBITDA-73.73M-130.55M56%
Gain YTD26.509-66.118-40%
P/E Ratio4.53N/A-
Revenue1.26M6.96M18%
Total Cash62.2M218M29%
Total Debt29.4M96.7M30%
FUNDAMENTALS RATINGS
DTIL: Fundamental Ratings
DTIL
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DTILTCRX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REOP54.740.99
+1.84%
Reo Plastics, Inc.
NDTP1.46N/A
N/A
NDT Pharmaceuticals Inc.
UVRBF1.05N/A
N/A
Universal Robina
CNTHN41.80N/A
N/A
Connecticut Light & Power Co. (The)
IAFNF116.75-1.74
-1.47%
IA FINL CORP INC.

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-7.66%
AXON - DTIL
46%
Loosely correlated
-0.50%
ORMP - DTIL
41%
Loosely correlated
+0.80%
ARRY - DTIL
39%
Loosely correlated
-2.47%
LEGN - DTIL
35%
Loosely correlated
-4.72%
TCRX - DTIL
32%
Poorly correlated
+4.03%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+4.03%
FATE - TCRX
40%
Loosely correlated
+2.94%
MGNX - TCRX
39%
Loosely correlated
-7.79%
CGEM - TCRX
37%
Loosely correlated
-1.05%
ELVN - TCRX
37%
Loosely correlated
-2.17%
RGNX - TCRX
37%
Loosely correlated
-2.84%
More